SCHEMBL6470931

SCHEMBL6470931

BrCOc1cccc2[nH]c3ccccc3c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 8/20 0.53
DNM1 Q05193 2/20 0.52
IMPDH2 P12268 1/20 0.49
IMPDH1 P20839 1/20 0.49
TLR4 O00206 5/20 0.48
ABCG2 Q9UNQ0 1/20 0.47
GABRP O00591 2/20 0.46
GABRD O14764 2/20 0.46
GABRA1 P14867 2/20 0.46
GABRB1 P18505 2/20 0.46
GABRG2 P18507 2/20 0.46
GABRB3 P28472 2/20 0.46
GABRA5 P31644 2/20 0.46
GABRA3 P34903 2/20 0.46
GABRA2 P47869 2/20 0.46
GABRB2 P47870 2/20 0.46
GABRA4 P48169 2/20 0.46
GABRE P78334 2/20 0.46
GABRA6 Q16445 2/20 0.46
GABRG1 Q8N1C3 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472027 0.87 ADRB2 (0.58) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL30692087 0.84 ADRB2 (0.59) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL6009074 0.83 ADRB2 (0.57) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL4052917 0.81 ADRB2 (0.67) ADRB2DNM1TLR4DRD2ADRB1
SCHEMBL30493558 0.80 ADRB2 (0.58) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL14046114 0.80 ADRB2 (0.61) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL6925186 0.80 ADRB2 (0.58) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL4893406 0.80 SRD5A2 (0.56) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL4627007 0.79 ADRB2 (0.60) ADRB2DNM1IMPDH2IMPDH1TLR4
SCHEMBL6921090 0.79 ADRB2 (0.50) ADRB2DNM1IMPDH2IMPDH1TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554262-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Glenmark Pharmaceuticals Limited (IN) 2005-07-20 EP disclosed
WO-2004037805-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2004-05-06 WO disclosed